Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
CHEK Check-Cap	$0.67 -1.7%	$0.74	$0.56 ▼ $3.04	$3.89M	0.19	311,290 shs	11,125 shs
DRCT Direct Digital	$0.41 -6.8%	$0.54	$0.38 ▼ $6.59	$7.75M	6.04	1.14 million shs	412,551 shs
NXL Nexalin Technology	$0.78 -2.6%	$1.05	$0.59 ▼ $4.49	$13.66M	3.69	173,463 shs	80,231 shs
SLGL Sol-Gel Technologies	$15.44 +1.2%	$9.51	$4.01 ▼ $16.89	$43.08M	1.21	22,568 shs	11,954 shs

Beginner's Guide To Retirement Stocks

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
CHEK Check-Cap	0.00%	+10.28%	-11.13%	-26.60%	-63.79%
DRCT Direct Digital	-4.14%	+7.82%	-19.28%	-13.34%	-85.90%
NXL Nexalin Technology	-3.91%	-13.42%	-21.06%	-36.60%	-18.17%
SLGL Sol-Gel Technologies	-1.29%	+4.38%	+91.94%	+104.15%	+281.25%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
CHEK Check-Cap	0.4327 of 5 stars	0.0	3.0	1.9	0.0	0.6
DRCT Direct Digital	2.7383 of 5 stars	3.5	3.0	1.6	2.5	0.6
NXL Nexalin Technology	3.0991 of 5 stars	3.5	5.0	3.0	1.7	0.0
SLGL Sol-Gel Technologies	2.941 of 5 stars	3.5	3.0	4.4	1.7	0.0

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
CHEK Check-Cap	0.00	N/A	N/A	N/A
DRCT Direct Digital	2.50	Moderate Buy	$6.00	1,363.41% Upside
NXL Nexalin Technology	3.00	Buy	$5.00	537.59% Upside
SLGL Sol-Gel Technologies	3.00	Buy	$40.00	159.07% Upside

Current Analyst Ratings Breakdown

Latest CHEK, DRCT, SLGL, and NXL Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target	Details
8/8/2025	DRCT Direct Digital	Zacks Research Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Hold

(Data available from 8/15/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
CHEK Check-Cap	N/A	N/A	N/A	N/A	$4.05 per share	N/A
DRCT Direct Digital	$62.29M	0.12	N/A	N/A	($1.30) per share	-0.32
NXL Nexalin Technology	$170K	80.36	N/A	N/A	$0.34 per share	2.31
SLGL Sol-Gel Technologies	$11.54M	3.73	N/A	N/A	$10.36 per share	1.49

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
CHEK Check-Cap	-$17.57M	-$3.00	N/A	∞	N/A	N/A	N/A	N/A	N/A
DRCT Direct Digital	-$6.24M	-$1.83	N/A	N/A	N/A	-25.99%	N/A	-36.29%	N/A
NXL Nexalin Technology	-$7.61M	-$0.76	N/A	∞	N/A	-5,057.14%	-209.20%	-186.87%	N/A
SLGL Sol-Gel Technologies	-$10.58M	-$4.70	N/A	N/A	N/A	-107.78%	-43.98%	-35.28%	8/15/2025 (Estimated)

Latest CHEK, DRCT, SLGL, and NXL Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/15/2025	Q4 2024	SLGL Sol-Gel Technologies	-$0.67	$4.17	+$4.84	$4.17	$2.86 million	$17.26 million
8/6/2025	Q2 2025	NXL Nexalin Technology	-$0.14	-$0.10	+$0.04	-$0.10	$0.04 million	$0.07 million
8/5/2025	Q2 2025	DRCT Direct Digital	-$0.96	-$0.23	+$0.73	-$0.23	$11.84 million	$10.14 million
5/23/2025	Q1 2025	SLGL Sol-Gel Technologies	N/A	-$3.20	N/A	-$3.20	N/A	$1.03 million

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
CHEK Check-Cap	N/A	N/A	N/A	N/A	N/A
DRCT Direct Digital	N/A	N/A	N/A	N/A	N/A
NXL Nexalin Technology	N/A	N/A	N/A	N/A	N/A
SLGL Sol-Gel Technologies	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
CHEK Check-Cap	N/A	N/A	N/A
DRCT Direct Digital	N/A	0.49	0.49
NXL Nexalin Technology	N/A	10.43	10.14
SLGL Sol-Gel Technologies	N/A	5.12	5.12

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
CHEK Check-Cap	1.07%
DRCT Direct Digital	4.02%
NXL Nexalin Technology	0.65%
SLGL Sol-Gel Technologies	26.18%

Insider Ownership

Company	Insider Ownership
CHEK Check-Cap	0.48%
DRCT Direct Digital	62.82%
NXL Nexalin Technology	25.26%
SLGL Sol-Gel Technologies	66.51%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
CHEK Check-Cap	80	5.85 million	5.82 million	Not Optionable
DRCT Direct Digital	60	18.91 million	7.03 million	Not Optionable
NXL Nexalin Technology	3	17.42 million	13.02 million	Not Optionable
SLGL Sol-Gel Technologies	50	2.79 million	933,000	Optionable

CHEK, DRCT, SLGL, and NXL Headlines

Recent News About These Companies

Sol-Gel Reports Second Quarter 2025 Financial Results and Provides Corporate Updates

August 15 at 8:02 AM | globenewswire.com

Sol-Gel Technologies Ltd. (SLGL) Stock Price Today - WSJ

July 25, 2025 | wsj.com

Sol-Gel Technologies Ltd. (SLGL) - Yahoo Finance

July 9, 2025 | finance.yahoo.com

SLGL Sol-Gel Technologies Ltd. - Seeking Alpha

June 26, 2025 | seekingalpha.com

Sol-Gel Technologies Ltd

June 21, 2025 | morningstar.comM

Sol Gel Tech Stock Price History

June 1, 2025 | investing.com

Sol-Gel Technologies Ltd.: Sol-Gel Reports First Quarter 2025 Results

May 23, 2025 | finanznachrichten.de

Sol-Gel Stock Tumbles Over Underwhelming Q1 Earnings: Retail Stays Pessimistic

May 23, 2025 | msn.com

Sol-Gel Technologies Reports Q1 2025 Financial Results and Increased R&D Expenses

May 23, 2025 | quiverquant.comQ

Sol-Gel Reports First Quarter 2025 Results

May 23, 2025 | globenewswire.com

Insider Buying: Sol-Gel Technologies CEO & Executive Chairman Bought US$98k Of Shares

May 3, 2025 | uk.finance.yahoo.com

This Sol-Gel Technologies Insider Increased Their Holding In The Last Year

May 2, 2025 | finance.yahoo.com

Sol-Gel Announces Reverse Share Split

May 1, 2025 | globenewswire.com

Sol-Gel, Mayne Pharma enter product purchase agreement

April 17, 2025 | markets.businessinsider.com

Sol-Gel Technologies Ltd.: Sol-Gel and Mayne Pharma Announce the Purchase of EPSOLAY and TWYNEO in the U.S.

April 17, 2025 | finanznachrichten.de

Sol-Gel and Mayne Pharma Announce the Purchase of EPSOLAY® and TWYNEO® in the U.S.

April 17, 2025 | globenewswire.com

Global Sol-Gel Coatings Market Research 2025-2035: Competitive Landscape, Functional Properties and Applications, End-users, Technology Fundamentals, Overview and Growth Analysis

April 7, 2025 | globenewswire.com

Sol-Gel Technologies Approves Reverse Share Split and Compensation Policy Renewal

April 1, 2025 | tipranks.com

SLGL Gears Up to Report Q4 Earnings: Here's What You Should Know

February 25, 2025 | zacks.com

Is Sol-Gel Technologies (NASDAQ:SLGL) In A Good Position To Deliver On Growth Plans?

February 7, 2025 | finance.yahoo.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

CHEK, DRCT, SLGL, and NXL Company Descriptions

Check-Cap NASDAQ:CHEK

$0.66 -0.01 (-1.70%)

Closing price 03:59 PM Eastern

Extended Trading

$0.65 -0.01 (-1.65%)

As of 04:31 PM Eastern

Check-Cap Ltd., a clinical stage medical diagnostics company, engages in the development of a capsule-based screening technology that utilizes ultra-low-dose X-rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities in Israel. Its C-Scan system consists of C-Scan Cap, an X-ray scanning capsule for detection of suspected polyps; C-Scan Track, a disposable system attached to the patient's back through biocompatible adhesive skin patches; and C-Scan View software, a client/server-based application that enables procedure data download from the C-Scan Track, data analysis, and report generation. Check-Cap Ltd. was incorporated in 2004 and is based in Isfiya, Israel.

Direct Digital NASDAQ:DRCT

$0.41 -0.03 (-6.80%)

Closing price 04:00 PM Eastern

Extended Trading

$0.41 +0.00 (+0.49%)

As of 04:20 PM Eastern

Direct Digital Holdings, Inc. operates as an end-to-end full-service programmatic advertising platform. The company's platform primarily focuses on providing advertising technology, data-driven campaign optimization, and other solutions to underserved and less efficient markets on both the buy- and sell-side of the digital advertising ecosystem. It serves various industry verticals, such as travel, healthcare, education, financial services, consumer products, and other sectors with a focus on small and mid-sized businesses. The company was founded in 2018 and is headquartered in Houston, Texas.

Nexalin Technology NASDAQ:NXL

$0.78 -0.02 (-2.61%)

Closing price 04:00 PM Eastern

Extended Trading

$0.79 +0.00 (+0.23%)

As of 04:04 PM Eastern

Nexalin Technology, Inc., a medical device company, designs and develops neurostimulation products for the treatment of mental health in the United States and China. The company designs and develops Generation 2 and Generation 3, that is in clinical trials for the treatment of substance abuse issues related to opiate, cocaine, alcohol abuse, alzheimer's disease, and dementia. It also licenses and sells Nexalin Device, a non-invasive and undetectable to the human body that can provide relief to its afflicted with mental health issues. The company is based in Houston, Texas.

Sol-Gel Technologies NASDAQ:SLGL

$15.44 +0.19 (+1.25%)

Closing price 04:00 PM Eastern

Extended Trading

$15.30 -0.15 (-0.94%)

As of 04:10 PM Eastern

Sol-Gel Technologies Ltd., together with its subsidiary Sol-Gel Technologies Inc., develops topical dermatological drugs for patients with severe skin conditions in Israel. The company offers Twyneo, a once-daily, non-antibiotic topical cream for the treatment of acne vulgaris; and Epsolay, a once-daily topical cream for the treatment of papulopustular (subtype II) rosacea. It also develops SGT-610 that is in Phase 3 clinical trials for the treatment of Gorlin Syndrome; and SGT-210, which has completed Phase I clinical trial, to treat rare hyperkeratinization disorders, such as Darier, PC, PPK, Olmsted, etc. In addition, the company is also involved in the development of generic topical dermatological drug products. It has collaboration with Padagis Israel Pharmaceuticals Ltd; and license agreements with Galderma Holding SA and Searchlight Pharma Inc. Sol-Gel Technologies Ltd. was incorporated in 1997 and is headquartered in Ness Ziona, Israel.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time